It is good to see production costs v. value add return comparisons with drugs as part of an ongoing drive to create drugs cheaper and making them cheaper to patients. However, lets do not sacrifice quality (especially in areas like cancer, MS, etc.) for costs of development/ cost savings. Value of life is priceless.
Defining the value of a drug in relation to its cost and benefit is an emerging theme in cancer care but remains untested.
Read more
Comments are closed.